Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis

Cytokine

Volumn 49, Issue 1, 2010, Pages 24-29

  Flytlie, Helene Aarslev ^a   Hvid, Malene ^a,b   Lindgreen, Esther ^a   Kofod Olsen, Emil ^a   Petersen, Eva Lykke ^a   Jørgensen, Anette ^b   Deleuran, Mette ^b   Vestergaard, Christian ^b   Deleuran, Bent ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Arthritis; CCR4; Chemokine; MDC; Psoriasis

Indexed keywords

C REACTIVE PROTEIN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR4; MACROPHAGE DERIVED CHEMOKINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEMORY T LYMPHOCYTE; MONONUCLEAR CELL; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; SYNOVIUM;

AGED; ANIMALS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CHEMOKINE CCL22; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; MIDDLE AGED; OSTEOARTHRITIS; RECEPTORS, CCR4; SKIN; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 71649111435     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.10.005     Document Type: Article

References (30)

1. Genta M.S., Genta R.M., and Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum 36 2 (2006) 88-98
2. Turesson C., Eberhardt K., Jacobsson L.T., and Lindqvist E. Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort. Ann Rheum Dis 66 11 (2007) 1543-1544
3. Gelfand J.M., Gladman D.D., Mease P.J., Smith N., Margolis D.J., Nijsten T., et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53 4 (2005) 573
4. Leonard D.G., O'Duffy J.D., and Rogers R.S. Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis. Mayo Clin Proc 53 8 (1978) 511-518
5. Zachariae H., Zachariae R., Blomqvist K., Davidsson S., Molin L., Mork C., et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol 82 2 (2002) 108-113
6. Fahy O., Porte H., Senechal S., Vorng H., McEuen A.R., Buckley M.G., et al. Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin. Am J Pathol 158 3 (2001) 1053-1063
7. Katschke Jr. K.J., Rottman J.B., Ruth J.H., Qin S., Wu L., LaRosa G., et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 44 5 (2001) 1022-1032
8. Cadosch D, Gautschi OP, Chan E, Simmen HP, Filgueira L. Titanium induced production of chemokines CCL17/TARC and CCL22/MDC in human osteoclasts and osteoblasts. J Biomed Mater Res A. doi:10.1002/jbm.a.32390.
9. Imai T., Nagira M., Takagi S., Kakizaki M., Nishimura M., Wang J., et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11 1 (1999) 81-88
10. Nakayama T., Hieshima K., Nagakubo D., Sato E., Nakayama M., Kawa K., et al. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 78 4 (2004) 1665-1674
11. Andrew D.P., Chang M.S., McNinch J., Wathen S.T., Rihanek M., Tseng J., et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol 161 9 (1998) 5027-5038
12. Gonzalo J.A., Pan Y., Lloyd C.M., Jia G.Q., Yu G., Dussault B., et al. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol 163 1 (1999) 403-411
13. Vestergaard C., Deleuran M., Gesser B., and Gronhoj Larsen C. Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Br J Dermatol 149 3 (2003) 457-463
14. Vestergaard C., Yoneyama H., Murai M., Nakamura K., Tamaki K., Terashima Y., et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104 8 (1999) 1097-1105
15. Yanai M., Sato K., Aoki N., Takiyama Y., Oikawa K., Kobayashi H., et al. The role of CCL22/macrophage-derived chemokine in allergic rhinitis. Clin Immunol 125 3 (2007) 291-298
16. + regulatory T cells. J Immunol 180 1 (2008) 122-129
17. Pitzalis C., Cauli A., Pipitone N., Smith C., Barker J., Marchesoni A., et al. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum 39 1 (1996) 137-145
18. Campbell J.J., O'Connell D.J., and Wurbel M.A. Cutting edge: chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions. J Immunol 178 6 (2007) 3358-3362
19. + T cells are resident in normal skin. J Immunol 176 7 (2006) 4431-4439
20. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 3 (1988) 315-324
21. Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., and Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54 8 (2006) 2665-2673
22. Kragstrup T.W., Otkjaer K., Holm C., Jorgensen A., Hokland M., Iversen L., et al. The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine 41 1 (2008) 16-23
23. Kane D., Stafford L., Bresnihan B., and FitzGerald O. A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis - 'DIP or not DIP revisited'. Rheumatology (Oxford) 42 12 (2003) 1469-1476
24. + CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA). Clin Exp Immunol 148 3 (2007) 515-519
25. Kruithof E., Baeten D., De Rycke L., Vandooren B., Foell D., Roth J., et al. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 7 3 (2005) R569-R580
26. Kohem C.L., Brezinschek R.I., Wisbey H., Tortorella C., Lipsky P.E., and Oppenheimer-Marks N. Enrichment of differentiated CD45RBdim, CD27-memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 39 5 (1996) 844-854
27. Cohen S.B., Cheng T.T., Chindalore V., Damjanov N., Burgos-Vargas R., Delora P., et al. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis. Arthritis Rheum 60 2 (2009) 335-344
28. Saklatvala J. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol 4 4 (2004) 372-377
29. Colville-Nash P.R., and Scott D.L. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 51 7 (1992) 919-925
30. D'Ambrosio D., Albanesi C., Lang R., Girolomoni G., Sinigaglia F., and Laudanna C. Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion. J Immunol 169 5 (2002) 2303-2312